Still in shock from a drain-off of capital, life sciences companies will keep hiring selective, strategic and slim in 2012.
Early-stage companies still need cash to feed their growth, but more mature companies that are on the cusp of launching a product expect to hire, mostly in sales. Job cuts will continue in manufacturing, where excess capacity at contract manufacturing organizations has made it more attractive for companies to shut down their own drug-making shops.
No comments:
Post a Comment